Location History:
- Orange Village, OH (US) (2012 - 2014)
- Cleveland, OH (US) (2018 - 2019)
Company Filing History:
Years Active: 2012-2019
Title: Thomas S. McCormick: Innovator in Cancer Detection
Introduction
Thomas S. McCormick is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of cancer diagnostics, holding a total of 4 patents. His work focuses on innovative methods for detecting cancer, particularly through the analysis of specific biomarkers.
Latest Patents
Among his latest patents is a method for diagnosing an increased risk of cancer in a subject. This method involves obtaining a blood sample and determining the levels of various polypeptides, including VNN2, KCNJ15, and others. An increase in the levels of these polypeptides compared to a control level indicates a heightened risk of cancer. Another significant patent involves detecting the presence of glioblastomas in a subject. This method isolates CD14+ cells from a blood sample and assesses the ratio of these cells expressing low levels of HLA-DR to those expressing VNN2. A specific ratio indicates an increased risk of glioblastomas or recurrent glioblastoma.
Career Highlights
Thomas S. McCormick is affiliated with Case Western Reserve University, where he continues to advance research in cancer detection. His innovative approaches have the potential to significantly impact early diagnosis and treatment strategies for cancer patients.
Collaborations
Some of his notable coworkers include Kevin D. Cooper and Andrew Young, who contribute to the collaborative research environment at Case Western Reserve University.
Conclusion
Thomas S. McCormick's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer diagnostics. His patents reflect a commitment to improving patient outcomes through advanced detection methods.